Xenon Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 65.42 USD | 72,66 USD | 30 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 80,929 USD | 14 | 5 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 96.665.550 | 6,56 | 3,26 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Xenon Pharmaceuticals Inc
Mitarbeiter 358
Handelsplatz NASDAQ
Ticker Symbol XENE
IPO Datum 2014-11-05
Adresse 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
Webseite https://www.xenon-pharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. | President, CEO & Director |
| 2 | Mr. Thomas Patrick Kelly J.D. | Chief Financial Officer |
| 3 | Ms. Andrea DiFabio J.D. | Chief Legal Officer & Corporate Secretary |
| 4 | Dr. Christopher John Kenney M.D. | Chief Medical Officer |
| 5 | Mr. Darren S. Cline M.B.A. | Chief Commercial Officer |
| 6 | Dr. Matthew D. Ronsheim Ph.D. | Chief Operating Officer |
| 7 | Ms. Shelley McCloskey B.A. | Executive Vice President of Human Resources |
| 8 | Dr. Robin P. Sherrington Ph.D. | Executive Vice President of Strategy & Innovation |
| 9 | Dr. James R. Empfield Ph.D. | Executive Vice President of Drug Discovery |
| 10 | Ms. Colleen Alabiso | Senior Vice President of Corporate Affairs |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | venBio Select Advisor LLC | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 5 | Driehaus Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | Polar Capital Holdings PLC | 0,00% | 0,00 Mio. USD |
| 7 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 8 | Capital Research & Mgmt Co - Division 3 | 0,00% | 0,00 Mio. USD |
| 9 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 10 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 11 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 12 | Affinity Asset Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 14 | Holocene Advisors, LP | 0,00% | 0,00 Mio. USD |
| 15 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |
| 16 | Westfield Capital Management Company, L.P. | 0,00% | 0,00 Mio. USD |
| 17 | Caligan Partners LP | 0,00% | 0,00 Mio. USD |
| 18 | BNP Paribas Investment Partners SA | 0,00% | 0,00 Mio. USD |
| 19 | BRAIDWELL LP | 0,00% | 0,00 Mio. USD |
| 20 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |